Xinyaqiang Silicon Chemistry Co.,Ltd (SHA:603155)
China · Delayed Price · Currency is CNY 23.06
-1.80 (-7.24%)
Jun 18, 2026, 3:00 PM CST
SHA:603155 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 597.14 | 565.49 | 689 | 654.28 | 1,094 | 850.01 |
Other Revenue | 26.39 | 26.39 | 31.54 | 20.93 | 39.49 | 29.98 |
| 623.53 | 591.88 | 720.54 | 675.2 | 1,134 | 880 | |
Revenue Growth (YoY) | -11.16% | -17.86% | 6.71% | -40.44% | 28.82% | 79.47% |
Cost of Revenue | 514.76 | 491.22 | 588.14 | 532.32 | 786.62 | 503.59 |
Gross Profit | 108.77 | 100.66 | 132.4 | 142.88 | 346.98 | 376.4 |
Selling, General & Admin | 22.47 | 23.36 | 21.22 | 22.95 | 21.12 | 19.79 |
Research & Development | 29.85 | 31.08 | 33.79 | 33.4 | 36.86 | 28.16 |
Other Operating Expenses | 3.2 | 2.87 | 4.03 | 7.77 | 6.46 | 5.36 |
Operating Expenses | 57.97 | 58.01 | 60.97 | 63.89 | 61.94 | 57.25 |
Operating Income | 50.81 | 42.65 | 71.43 | 79 | 285.04 | 319.15 |
Interest Expense | - | - | -0.52 | -0.63 | -0.23 | - |
Interest & Investment Income | 13.45 | 12.52 | 17.79 | 19.68 | 12.79 | 18.11 |
Currency Exchange Gain (Loss) | 1.94 | 1.94 | 15.41 | 6.84 | 14.47 | -4.88 |
Other Non Operating Income (Expenses) | -4.16 | -0.33 | -0.2 | -0.21 | -0.27 | -0.19 |
EBT Excluding Unusual Items | 62.03 | 56.78 | 103.91 | 104.68 | 311.8 | 332.19 |
Gain (Loss) on Sale of Investments | 23.23 | 24.43 | 21.48 | 32.4 | 33.81 | 32.34 |
Gain (Loss) on Sale of Assets | 4.84 | 4.84 | 0.04 | -0.07 | -0.13 | 0.97 |
Other Unusual Items | 8.11 | 8.11 | 5.4 | 4.29 | 0.93 | 3.85 |
Pretax Income | 98.21 | 94.15 | 130.82 | 141.3 | 346.4 | 369.35 |
Income Tax Expense | 12.36 | 11.57 | 16.68 | 18.2 | 44.77 | 49.91 |
Earnings From Continuing Operations | 85.84 | 82.58 | 114.14 | 123.1 | 301.64 | 319.44 |
Minority Interest in Earnings | -0.84 | -0.69 | 0.22 | 0.34 | 0.08 | - |
Net Income | 85 | 81.89 | 114.36 | 123.44 | 301.72 | 319.44 |
Net Income to Common | 85 | 81.89 | 114.36 | 123.44 | 301.72 | 319.44 |
Net Income Growth | -24.07% | -28.39% | -7.36% | -59.09% | -5.55% | 103.03% |
Shares Outstanding (Basic) | 306 | 315 | 318 | 317 | 315 | 315 |
Shares Outstanding (Diluted) | 306 | 315 | 318 | 317 | 315 | 315 |
Shares Change (YoY) | -6.50% | -0.85% | 0.36% | 0.40% | 0.10% | 19.32% |
EPS (Basic) | 0.28 | 0.26 | 0.36 | 0.39 | 0.96 | 1.01 |
EPS (Diluted) | 0.28 | 0.26 | 0.36 | 0.39 | 0.96 | 1.01 |
EPS Growth | -18.79% | -27.78% | -7.69% | -59.25% | -5.64% | 70.16% |
Free Cash Flow | 38.58 | 16.76 | 150.66 | 126.97 | 69.65 | 102.88 |
Free Cash Flow Per Share | 0.13 | 0.05 | 0.47 | 0.40 | 0.22 | 0.33 |
Dividend Per Share | 0.500 | 0.500 | 0.700 | - | 0.714 | 0.493 |
Dividend Growth | -28.57% | -28.57% | - | - | 45.01% | 81.84% |
Gross Margin | 17.45% | 17.01% | 18.38% | 21.16% | 30.61% | 42.77% |
Operating Margin | 8.15% | 7.21% | 9.91% | 11.70% | 25.14% | 36.27% |
Profit Margin | 13.63% | 13.84% | 15.87% | 18.28% | 26.62% | 36.30% |
Free Cash Flow Margin | 6.19% | 2.83% | 20.91% | 18.80% | 6.14% | 11.69% |
EBITDA | 94.62 | 87.33 | 119.58 | 126.01 | 323.15 | 343.98 |
EBITDA Margin | 15.18% | 14.75% | 16.60% | 18.66% | 28.51% | 39.09% |
D&A For EBITDA | 43.82 | 44.69 | 48.15 | 47.01 | 38.11 | 24.83 |
EBIT | 50.81 | 42.65 | 71.43 | 79 | 285.04 | 319.15 |
EBIT Margin | 8.15% | 7.21% | 9.91% | 11.70% | 25.14% | 36.27% |
Effective Tax Rate | 12.59% | 12.29% | 12.75% | 12.88% | 12.92% | 13.51% |
Revenue as Reported | 623.53 | 591.88 | 720.54 | 675.2 | 1,134 | 880 |
Advertising Expenses | - | 0.09 | 0.19 | 0.23 | 0.01 | 0.13 |